NCT04148924

Brief Summary

In palliative care, anxiety and depression in advanced cancer are under evaluated, under diagnosed and therefore under treated. 5 to 30% of patients present anxious and depressive disorders. Physical symptoms are easy to assess. But in palliative care it is important to take care of moral suffering. However, evaluation and management of patient's anxiety and depressive symptoms are difficult for physicians and caregivers. The investigators would like to specifically compare the patient's evaluation of anxious and depressive symptomatology in palliative care with the evaluation by the physician, the nurse and the caregiver. Then the investigators will try to collect the caregivers's difficulties in the management of anxious and depressive symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 4, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

November 15, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2020

Completed
Last Updated

July 27, 2021

Status Verified

July 1, 2021

Enrollment Period

12 months

First QC Date

October 31, 2019

Last Update Submit

July 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of the anxious and depressive symptomatology of hospitalized patients in palliative care unit (USP) evaluated on the one hand by the patient himself and on the other hand, in hetero evaluation, by caregivers.

    The Edmonton Symptom Assessment Scale (ESAS) will be used for assess anxiety and depression intensity. The ESAS is a self-reported outcome tool assessing the intensity of nine symptoms (pain, tiredness, nausea, depressive mood, anxiety, drowsiness, lack of appetite, wellbeing, and breathlessness). Intensity is rated using 10-point Likert-scales from "no-symptom" (scored 0) to "worst possible symptom" (scored 10) The difference of evaluation for anxiety and depressive symptoms is considere significant when there are two points and more between ESAS patient's and ESAS caregivers'.

    72 hours

Study Arms (4)

Patients

Anyone who is hospitalized in the palliative care service of the Lyon Sud Hospital Center.

Other: Questionnaire

Doctors

Doctors taking care of patients in the study will be solicited by the research nurse or a study investigator.

Other: Medical staff questionnaire

Nurses

Nurses taking care of patients in the study will be solicited by the research nurse or a study investigator.

Other: Medical staff questionnaire

Caregivers

Caregivers taking care of patients in the study will be solicited by the research nurse or a study investigator.

Other: Medical staff questionnaire

Interventions

Patients complete a questionnaire for assess their symptoms like anxiety and depression. These questionnaires contains: * socio-demographic characteristics : sex, age, type and stage of cancer, performans status * ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms * HADS - A : Hospital Anxiety and Depression scale includes 2 subscales which assess anxiety (HADS-A) and depression (HADS-D) * BEDS : Brief Edimburg depression Scale is s a relevant scale for assess depression in palliative care patients. * Questions on the assessment, the treatment and difficulties in management of anxious and depressive symptoms. The evaluation will be realized in the first days of hospitalization (72 hours).

Patients

Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours). Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit. These questionnaires contains: * socio-demographic characteristics : sex, age, type and stage of cancer, performans status * ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms

CaregiversDoctorsNurses

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients hospitalized in our palliative care unit

You may qualify if:

  • Patients :
  • Adult patients (18 years and over)
  • Advanced cancer stage
  • Patients hospitalized less than 72 hours in Lyon Sud palliative care unit
  • Sufficient general conditions to complete survey
  • Absence of cognitive disorders
  • Agreement to participate at the study
  • Medical Staff:
  • \- Working full time or part time in the USP or the PMSC of CHLS

You may not qualify if:

  • Patients :
  • Minor patients
  • Patients hospitalized more than 72 hours in Lyon Sud palliative care unit
  • Presence of cognitive disorders
  • Alteration of general conditions
  • Refusal to participate at the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Lyon Sud

Pierre-Bénite, France

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Audrey FAWOUBO, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2019

First Posted

November 4, 2019

Study Start

November 15, 2019

Primary Completion

November 13, 2020

Study Completion

November 13, 2020

Last Updated

July 27, 2021

Record last verified: 2021-07

Locations